Parkman Healthcare Partners LLC
STAMFORD, CT · CIK 1777015 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2019 · limited liability company
- Assets managed$1.7bn
- Staff12 · 8 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $718.9m gross assets
- Form ADV · 2026-03-27SEC adviser record
- Legal entityPARKMAN HEALTHCARE PARTNERS LLC (US)
$973.7m
reported value
+0.9% vs Q1 2026
76positions
33.6%in top 10
17 new
27 added
30 reduced
30 sold out
vs Q1 2026
Options: 0 call positions (— notional), 1 put positions ($3.1m notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| MBX BIOSCIENCES INC MBX | $44.2m4.54% | Added +136 |
| ELI LILLY & CO LLY | $42.0m4.31% | Added +384 |
| CVS HEALTH CORP CVS | $40.5m4.16% | Added +4.5k |
| DEXCOM INC DXCM | $36.0m3.70% | Reduced -155.1k |
| PTC THERAPEUTICS INC PTCT | $35.5m3.65% | Added +4.3k |
| ARCUS BIOSCIENCES INC RCUS | $28.3m2.91% | Reduced -288.0k |
| STRUCTURE THERAPEUTICS INC GPCR | $26.1m2.68% | Added +253.6k |
| VIRIDIAN THERAPEUTICS INC VRDN | $25.3m2.60% | Added +819.6k |
| AGIOS PHARMACEUTICALS INC AGIO | $24.8m2.55% | Added +265.5k |
| INHIBRX BIOSCIENCES INC INBX | $24.3m2.50% | New |
| XENON PHARMACEUTICALS INC XENE | $24.0m2.46% | Reduced -99.7k |
| EDGEWISE THERAPEUTICS INC EWTX | $23.4m2.41% | Added +254.2k |
| UNITEDHEALTH GROUP INC UNH | $23.2m2.39% | New |
| STRYKER CORPORATION SYK | $21.4m2.20% | Reduced -86.8k |
| IQVIA HLDGS INC IQV | $20.4m2.10% | Added +19.1k |
| ZIMMER BIOMET HOLDINGS INC ZBH | $20.0m2.06% | Reduced -37.0k |
| INSULET CORP PODD | $20.0m2.05% | Reduced -25.2k |
| ASSEMBLY BIOSCIENCES INC ASMB | $19.8m2.04% | Added +310.0k |
| SYNDAX PHARMACEUTICALS INC SNDX | $19.2m1.97% | Reduced -24.3k |
| EYEPOINT PHARMACEUTICALS INC EYPT | $18.4m1.89% | Reduced -66.6k |
| TENET HEALTHCARE CORP THC | $18.2m1.87% | Added +47.2k |
| LIVANOVA PLC LIVN | $17.3m1.78% | Reduced -193.4k |
| ANI PHARMACEUTICALS INC ANIP | $16.8m1.73% | Reduced -77.7k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $16.2m1.67% | Reduced -83.8k |
| ALNYLAM PHARMACEUTICALS INC ALNY | $15.3m1.57% | Added +23.8k |
| INDIVIOR PHARMACEUTICALS INC INDV | $14.9m1.53% | New |
| ENVISTA HOLDINGS CORPORATION NVST | $14.6m1.50% | Reduced -157.8k |
| BRIGHT MINDS BIOSCIENCES INC DRUG | $14.4m1.48% | Added +165.0k |
| XERIS BIOPHARMA HOLDINGS INC XERS | $14.3m1.47% | Added +86.4k |
| AVALO THERAPEUTICS INC AVTX | $14.2m1.45% | New |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $12.6m1.30% | Added +425.6k |
| IMMUNOME INC IMNM | $12.6m1.29% | Added +190.7k |
| STOKE THERAPEUTICS INC STOK | $11.6m1.19% | Added +18.9k |
| WATERS CORP WAT | $11.3m1.16% | Added +3.8k |
| ALTO NEUROSCIENCE INC ANRO | $11.3m1.16% | New |
| ORUKA THERAPEUTICS INC ORKA | $10.8m1.11% | New |
| ADAPTIVE BIOTECHNOLOGIES COR ADPT | $10.4m1.07% | Reduced -64.8k |
| ABSCI CORPORATION ABSI | $10.4m1.06% | Reduced -970.4k |
| MINERALYS THERAPEUTICS INC MLYS | $10.3m1.05% | Added +217 |
| COGENT BIOSCIENCES INC COGT | $9.8m1.01% | Added +153.2k |
| UNIQURE NV QURE | $9.6m0.98% | Added +1.3k |
| TARSUS PHARMACEUTICALS INC TARS | $9.4m0.97% | New |
| AMNEAL PHARMACEUTICALS INC AMRX | $9.4m0.96% | Added +240.4k |
| IRHYTHM TECHNOLOGIES INC IRTC | $8.0m0.82% | Added +27.1k |
| CRYOPORT INC CYRX | $8.0m0.82% | New |
| BOSTON SCIENTIFIC CORP BSX | $7.7m0.79% | Reduced -268.3k |
| CLIMB BIO INC CLYM | $7.3m0.75% | New |
| AMYLYX PHARMACEUTICALS INC AMLX | $7.2m0.74% | Reduced -222.7k |
| UPSTREAM BIO INC UPB | $6.5m0.66% | Added +148.5k |
| RESMED INC RMD | $6.4m0.66% | New |
| UROGEN PHARMA LTD URGN | $6.4m0.66% | Reduced -100.9k |
| ALIGN TECHNOLOGY INC ALGN | $6.2m0.64% | Added +15.7k |
| CARLSMED INC CARL | $6.2m0.64% | Added +76.2k |
| AVEANNA HEALTHCARE HLDGS INC AVAH | $6.1m0.63% | New |
| CAREDX INC CDNA | $5.8m0.59% | Reduced -89.0k |
| SI-BONE INC SIBN | $5.4m0.55% | Reduced -44.9k |
| VIR BIOTECHNOLOGY INC VIR | $4.8m0.50% | Reduced -24.7k |
| ERASCA INC ERAS | $4.7m0.49% | Reduced -148.0k |
| SHOULDER INNOVATIONS INC SI | $4.6m0.47% | New |
| WAYSTAR HLDG CORP WAY | $4.2m0.43% | Reduced -239.1k |
| ALPHATEC HLDGS INC ATEC | $3.9m0.40% | Reduced -373.8k |
| ANNEXON INC ANNX | $3.7m0.38% | Reduced -33.0k |
| CASTLE BIOSCIENCES INC CSTL | $3.5m0.35% | Added +18.6k |
| MINIMED GROUP INC MMED | $3.4m0.35% | Reduced -90.9k |
| EIKON THERAPEUTICS INC EIKN | $3.3m0.34% | New |
| VIATRIS INC VTRS | $3.2m0.33% | New |
| ARTIVION INC AORT | $3.1m0.32% | Reduced -113.1k |
| AXSOME THERAPEUTICS INC AXSM | $2.4m0.25% | New |
| OPTIMIZERX CORP OPRX | $2.0m0.21% | Reduced -379.0k |
| INSPIREMD INC NSPR | $1.7m0.17% | Unchanged |
| HEMAB THERAPEUTICS HLDGS INC COAG | $1.7m0.17% | New |
| PULMONX CORP LUNG | $840.5k0.09% | Reduced -109.1k |
| ARS PHARMACEUTICALS INC SPRY | $822.6k0.08% | New |
| EDAP TMS S A FOCL | $802.0k0.08% | Unchanged |
| OVID THERAPEUTICS INC OVID | $532.5k0.05% | Reduced -10.3k |
| ENTERA BIO LTD ENTX | $485.9k0.05% | Reduced -14.2k |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| KALVISTA PHARMACEUTICALS INC KALV | $36.9m1.8m shares |
| QIAGEN NV QGEN | $20.0m500.0k shares |
| ABBVIE INC ABBV | $16.3m75.0k shares |
| ILLUMINA INC ILMN | $13.6m110.4k shares |
| EDWARDS LIFESCIENCES CORP EW | $13.4m167.2k shares |
| NEUROCRINE BIOSCIENCES INC NBIX | $13.1m99.1k shares |
| KINIKSA PHARMACEUTICALS INTL KNSA | $12.5m259.2k shares |
| MCKESSON CORP MCK | $11.0m12.7k shares |
| NUVALENT INC | $9.0m88.1k shares |
| AXOGEN INC AXGN | $8.9m268.2k shares |
| IDEXX LABS INC IDXX | $8.4m15.0k shares |
| APOGEE THERAPEUTICS INC | $6.5m77.7k shares |
| COOPER COS INC COO | $6.4m89.9k shares |
| TANGO THERAPEUTICS INC TNGX | $5.6m266.1k shares |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $4.9m235.0k shares |
| SUPERNUS PHARMACEUTICALS INC SUPN | $4.4m85.1k shares |
| CARIS LIFE SCIENCES INC CAI | $4.1m229.9k shares |
| CVRX INC CVRX | $4.1m429.5k shares |
| GENEDX HOLDINGS CORP WGS | $3.3m50.8k shares |
| VERACYTE INC VCYT | $3.3m101.2k shares |
| COMPASS PATHWAYS PLC CMPS | $3.1m554.4k shares |
| SOLID BIOSCIENCES INC SLDB | $2.2m308.8k shares |
| BUTTERFLY NETWORK INC BFLY | $2.2m544.5k shares |
| QUIDELORTHO CORP QDEL | $1.7m101.8k shares |
| RXSIGHT INC RXST | $1.5m250.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| GRAIL INC GRAL · Put | $3.1m46.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| INSPIREMD INC NSPR · 13G · filed 2025-11-14 | 5.8%≈ $1.7m |